Camillo Porta

2 ta ish

University of Bari Aldo Moro

1. Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

   Matteo Santoni, Sebastiano Buti, Zin Myint +63

   Maqola20233 iqtibos

   ABIABI:AkademIndex/2026.other.839256

2. Sorafenib in Advanced Hepatocellular Carcinoma

   Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro +21

   Maqola20082 iqtibos

   ABIABI:AkademIndex/2026.other.548030